MOOSTIN 40MG TABLET

MOOSTIN 40MG TABLET is an anti-cancer medicine used in the treatment of brain tumors. A tumor is defined as the formation of solid mass tissue due to the abnormal growth of cells. MOOSTIN 40MG TABLET is used in the treatment of primary and metastatic brain tumors along with appropriate surgical or radiotherapeutic procedures. A brain tumor is a serious condition where the cells (cancerous or non-cancerous) grow abnormally in the brain. MOOSTIN 40MG TABLET is also used in the treatment of Hodgkin’s Disease when used in combination with other chemotherapies.

MOOSTIN 40MG TABLET contains Lomustine, which belongs to the alkylating agents class. It works by inhibiting the DNA and RNA transcription that is essential for protein synthesis. This causes shrinkage of tumor cells and thereby prevents the growth and further spread of cancerous or non-cancerous cells.

MOOSTIN 40MG TABLET may cause certain side effects, such as nausea, vomiting, headache, visual disturbances, blindness, disorientation, lack of energy, loss of control, and difficulty talking. These side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor. MOOSTIN 40MG TABLET should be taken as prescribed by your doctor. Do not take more than the recommended dose of medicine.

MOOSTIN 40MG TABLET should be avoided if you are allergic to it or any other components present in it. MOOSTIN 40MG TABLET may cause pulmonary toxicity, delayed myelosuppression, pulmonary fibrosis, nephrotoxicity, and hepatotoxicity in some patients. Hence, careful monitoring should be done during the entire treatment. This medicine is known to cause embryo-fetal harm in pregnant women. Hence, inform your doctor if you are pregnant or are planning to become pregnant. It is unknown whether MOOSTIN 40MG TABLET is suitable for children's use. Hence, please consult your doctor or paediatrician for information on children's use. Breastfeeding should be discontinued in nursing mothers during the treatment. MOOSTIN 40MG TABLET should only be taken once in 6 weeks as taking more than the recommended dose can cause serious life-threatening problems. Hence, talk to your doctor or pharmacist before starting the treatment. 

MOOSTIN 40MG TABLET contains Lomustine, which belongs to the alkylating agents class. It works by inhibiting the DNA and RNA transcription that is essential for protein synthesis. This causes shrinkage of tumor cells and thereby prevents the growth and further spread of cancerous or non-cancerous cells.

MOOSTIN 40MG TABLET should be avoided if you are allergic to it or any other components present in it. Let your doctor know about your complete medical history, including current medication, to rule out any side effects/interactions. This medicine can cause a severe decrease in the number of blood cells in your bone marrow. A decrease in the number of blood cells in your body may cause certain symptoms and increase the risk of developing a serious infection or bleeding. Before administration, inform your doctor if you have liver/kidney disease, blood disorders, or respiratory conditions. MOOSTIN 40MG TABLET may cause pulmonary toxicity, delayed myelosuppression, pulmonary fibrosis, secondary malignancies, nephrotoxicity, and hepatotoxicity in some patients. Hence, careful monitoring should be done during the entire treatment. MOOSTIN 40MG TABLET is known to cause embryo-fetal harm in pregnant women. Hence, inform your doctor if you are pregnant or are planning to become pregnant. Breastfeeding should be discontinued in nursing mothers during the treatment. MOOSTIN 40MG TABLET should be given in children only if prescribed by the paediatrician. Avoid alcohol consumption and smoking, as it can lead to serious adverse effects. MOOSTIN 40MG TABLET may cause visual disturbances as a side effect. Hence, avoid driving vehicles or operating machines until you can see clearly. MOOSTIN 40MG TABLET should be taken once in 6 weeks only. Hence, talk to your doctor or pharmacist before starting the treatment.

• A blood test should be performed, such as LFT, RFT, and PFT, to check for liver/kidney function and pulmonary function.
• Weekly blood tests should be done during the treatment course to check for CBC (Complete blood count).
• MOOSTIN 40MG TABLET should not be taken more than the prescribed dose as it can lead to fatal toxicities and death.
• MOOSTIN 40MG TABLET should always be taken on an empty stomach only to avoid nausea.
• The patient's stool, urine and vomit should be discarded carefully by the caregiver. Gloves should be worn to avoid any contamination.